Related Articles
Aberrant promoter methylation of EDNRB in lung cancer in Taiwan
Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation
Tumor-derived aberrant methylation in plasma of invasive ductal breast cancer patients: Clinical implications
Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review)
Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma